Ipamorelin vs Sermorelin

Historically yes, and this was standard clinical practice before ipamorelin hit Category 2. Sermorelin (GHRH) and ipamorelin (GHRP) hit two different receptors, so combining them produces a larger GH pulse than either alone without additional side effects. Typical dosing was 200-300mcg of each at bedtime. The combination is no longer legitimately compoundable because ipamorelin cannot be sourced through 503A pharmacies. Some clinics have substituted tesamorelin for sermorelin in their newer protocols.

They hit different receptors so raw potency comparison is apples and oranges. Ipamorelin tends to produce a faster, sharper GH pulse. Sermorelin produces a more physiologic pulse that mirrors your natural endogenous pattern. Per injection, ipamorelin's GH output is typically larger. But the real answer is you get meaningfully more with both combined than with either alone - which is why they were almost always stacked when both were legally available.

Sermorelin got FDA approved in 1997, which means it has an existing drug master file and compounding pharmacies can produce it off-label under 503A rules. Ipamorelin never reached FDA approval. When the FDA placed it on Category 2 in September 2023, it removed the only legal supply pathway (503A compounding) that existed for it. Ipamorelin is on the February 2026 reclassification review list, but status has not changed yet.

Legitimate anti-aging and HRT clinics charge $150-350 per month for sermorelin, which usually includes the compound, the prescribing physician visit, and baseline labs (IGF-1, GH, thyroid, testosterone if relevant). Telehealth providers run slightly cheaper, around $99-200 per month, with lighter clinical supervision. Compared to recombinant HGH at $1,500-5,000+ per month, sermorelin is the affordable GH-axis option for adults with age-related decline.

Ipamorelin works via Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH. Sermorelin works via Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH. They differ in FDA approval status, efficacy data, and cost.

Ipamorelin typically costs $35 - $70/mo, while Sermorelin costs $150 - $350/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.

Ipamorelin is not FDA-approved (Category 2 (pending reclassification)). Sermorelin is not FDA-approved (Withdrawn (off-label use continues)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.

Common side effects of Ipamorelin include Injection site reactions, Increased hunger, Headache. Common side effects of Sermorelin include Injection site reactions, Flushing, Headache. Always consult a healthcare provider about potential side effects.

Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.